期刊文献+

地塞米松、环孢素A对慢性特发性血小板减少性紫癜患者淋巴细胞凋亡的影响 被引量:4

The induction of apoptosis in peripheral blood lymphocytes from the patients with chronic idiopathic thrombocytopenic purpura following treatment with dexamethasone and ciclosporin A
原文传递
导出
摘要 目的研究在体外条件下,地塞米松和环孢素A对慢性特发性血小板减少性紫癜患者外周血淋巴细胞凋亡的影响。方法用流式细胞仪测经地塞米松和环孢素A处理过的慢性特发性血小板减少性紫癜患者淋巴细胞凋亡率。结果用地塞米松、环孢素A处理过的慢性特发性血小板减少性紫癜患者淋巴细胞凋亡率明显高于对照组(P〈0.01)。结论地塞米松和环孢素A能增加慢性特发性血小板减少性紫癜患者淋巴细胞凋亡,是有效的免疫抑制药物,能针对慢性特发性血小板减少性紫癜患者细胞免疫异常的发病机制进行治疗。 Objectives To explore the induction of apoptosis in peripheral blood lymphocytes from the patients with chronic idiopathic thrombocytopenic purpura(CITP) following treatment in vitro with dexamethasone and cielosporin A. Methods The percentages of apoptosis of lymphoeytes from patients with CITP were analyzed by flow cytometry. Results The percentage of apoptosis of lymphocytes following treatment with dexamethasone was significantly higher than the one in the control group ( P 〈0. 01 ). And the percentage of apoptosis of lymphocytes following treatment with ciclosporin A was also higher than those in the control group( P 〈 0.01 ). Conclusion Dexamethasone and cielosporin A can both increase the percentages of apoptosis of lymphocytes from patients with CITP. They are effective immunosuppressive drugs which can correct the abnormal pathogenesis of cellar immunity of CITP.
作者 庄唯 高清平
出处 《临床内科杂志》 CAS 2009年第1期41-43,共3页 Journal of Clinical Internal Medicine
关键词 慢性特发性血小板减少性紫癜 淋巴细胞 凋亡 地塞米松 环孢素A Chronic idiopathic thrombocytopenic purpura Lymphocyte Apoptosis Dexamethasone Ciclosporin A
  • 相关文献

参考文献3

二级参考文献19

  • 1Zhu M,Terasawa H,Gulley J,et al.Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.Cancer Res,2001,61:3725-3734.
  • 2Zhang S,LawlessVA,Kaplan MH.Cytokine-stimulated T lymphocyte proliferation in regulated by p27kipl.J Immunol,2000,165:6270-6277.
  • 3Hodge JW,Rad AN,Grosenbach DW,et al.Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.J Natl Cancer Inst,2000,92:1228-1239.
  • 4Appleman LJ,van Puijenbroek AA,Sbu KM,et al.CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.J Immunol,2002,168:2729-2736.
  • 5Lee HW,Nam KO,See SK,et al.4-1BB cross-linking enhances the survival and cell cycle progression of CD4 T lymphocytes.Cell Immunol.2003,223:143-150.
  • 6De Souza CP,Ellem KA.Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.Exp Cell Res,2000,257:11-21.
  • 7Mouzaki A,Theodoropoulou M,Gianakopoulos I,et al.Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment:their role in prognosis.Blood,2002,100:1774-1779.
  • 8Panitsas FP,Theodoropoulou M,Kouraklis A,et al.Adult chronic idiopathic thrombocytopenic purpura(ITP) is the manifestation of a type-1 polarized immune response.Blood,2004,103:2645-2647.
  • 9Balomenos D,Mantinez-A C.Cell-cycle regulation in immunity,tolerance and autoimmunity.Immunology Today,2000,21:551-555.
  • 10HouM,LvB,HeQ etal.BothsplenicCD5+BandCD5-Bcellsproduceplateletglycoprotein specificautoantibodiesinchronicITP[].Thrombosis Research.2003

共引文献18

同被引文献43

  • 1鲍静,夏瑞祥,曾庆曙,李嘉嘉.外周血淋巴细胞亚群变化在特发性血小板减少性紫癜中的意义[J].安徽医科大学学报,2007,42(2):211-214. 被引量:11
  • 2侯明.成人ITP诊断和治疗专家共识.中华血液学杂志,2009,30(9):574-575.
  • 3Rodeghiero F,Stasi R,Gemsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group.Blood,2009,113(11):2386-2393.
  • 4Beardsley DS.ITP in the 21st century.Hematology,2006,40(1):402-407.
  • 5Provan D,Newland A,Belton-Maggs P,et al.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults,children and in pregnancy.Br J Haematol,2003,120(4):574-596.
  • 6Borst F,Keuning JJ,Van Hulsteijn H,et al.High-dose dexamethasone as first-and second·line treatment of idiopathic thrombocytopenic purpura in adults.Ann Hematol,2004,83(12):764-768.
  • 7Guo C,Chu X,Shi Y,et al.Correction of Th1 dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.Clin Immunol,2007,42(27):557-562.
  • 8Godeau B,Bierling P.Treatment of idiopathic thrombocytopenic purpura in adults.Presse Med,2008,37(8):1292-1298.
  • 9Chang M,Suen Y,Meng G,et al.Differential mechamisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia insight into the regulation of production.Blood,2001,88(9):3354-3362.
  • 10Cantor SB,Ehing LS,Hudson DV,et al.Pharmacoeconomie analysis of oprelvekin(recombinant human interleukin-11)for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.Cancer,2003,97(12):3099-3106.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部